International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.
Follow-Up Questions
International Isotopes Inc (INIS) 的市盈率是多少?
International Isotopes Inc 的市盈率是 3641.8848
International Isotopes Inc 的 CEO 是谁?
Mr. Shahe Bagerdjian 是 International Isotopes Inc 的 President,自 2023 加入公司。
INIS 股票的价格表现如何?
INIS 的当前价格为 $0.1081,在上个交易日 decreased 了 0%。
International Isotopes Inc 的主要业务主题或行业是什么?
International Isotopes Inc 属于 Life Sciences Tools & Services 行业,该板块是 Health Care